FMO5

FMO5
Identifikatori
Alijasi	FMO5
Spoljašnji ID	OMIM: 603957 MGI: 1310004 HomoloGene: 68185 GeneCards: FMO5
Genska lokacija (miš) Hr. Chromosome 3 (mouse) Band 3|3 F2.2 Start 97,536,120 bp Kraj 97,562,598 bp
Obrazac RNK izražavanja More reference expression data
Genska ontologija Molecular function • oxidoreductase activity • N,N-dimethylaniline monooxygenase activity • NADP binding • flavin adenine dinucleotide binding • monooxygenase activity Cellular component • organelle membrane • саставни део мембране • endoplasmic reticulum membrane • ендоплазматични ретикулум • мембрана • intracellular membrane-bounded organelle • цитосол Biological process • GO:0022610 биолошки процес Sources:Amigo / QuickGO
Ortolozi
Vrste	Čovek	Miš
Entrez	2330	14263
Ensembl	ENSG00000131781	ENSMUSG00000028088
UniProt	P49326	P97872
RefSeq (mRNA)	NM_001144829 NM_001144830 NM_001461	NM_001161763 NM_001161765 NM_010232 NM_001355119
RefSeq (protein)	NP_001138301 NP_001138302 NP_001452	NP_001155235 NP_001155237 NP_034362 NP_001342048
Location (UCSC)	n/a	Chr 3: 97.54 – 97.56 Mb
PubMed search
Wikidata
View/Edit Human View/Edit Mouse

Dimetilanilin monooksigenaza (N-oksid-formirajuća) 5 je enzim koji je kod ljudi kodiran FMO5 genom.

Metabolička N-oksidacija amino-trimetilamina (TMA) iz hrane je posredovana monooksigenazom koja sadrži flavin. Ovaj gen ispoljava nasledni FMO3 polimorfizam kod ljudi koji rezultira u maloj potpopulaciji sa umanjenom TMA N-oksidacionom sposobnošću, posledica čega je sindrom zadaha ribe, trimetilaminurija. Tri forme ovog enzima, FMO1 u fetalnoj jetri, FMO2 u jetri odraslih osoba, i FMO3 su kodirani genima koji su grupisani u 1q23-q25 regionu. Monooksigenze koje sadrže flavin su NADPH zavisni flavoenzimi koji katalizuju oksidaciju nukleofilnih heteroatomskih centera ksenobiotika kao što su pesticidi i lekovi.

Vidi još

• Dimetilanilin monooksigenaza (formiranje N-oksida)

Literatura

• Hines RN, Cashman JR, Philpot RM, et al. (1994). „The mammalian flavin-containing monooxygenases: molecular characterization and regulation of expression.”. Toxicol. Appl. Pharmacol. 125 (1): 1—6. PMID 8128486. doi:10.1006/taap.1994.1042. 
• Phillips IR, Dolphin CT, Clair P, et al. (1995). „The molecular biology of the flavin-containing monooxygenases of man.”. Chem. Biol. Interact. 96 (1): 17—32. PMID 7720101. doi:10.1016/0009-2797(94)03580-2. 
• Overby LH, Buckpitt AR, Lawton MP, et al. (1995). „Characterization of flavin-containing monooxygenase 5 (FMO5) cloned from human and guinea pig: evidence that the unique catalytic properties of FMO5 are not confined to the rabbit ortholog.”. Arch. Biochem. Biophys. 317 (1): 275—84. PMID 7872795. doi:10.1006/abbi.1995.1163. 
• Maruyama K, Sugano S (1994). „Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides.”. Gene. 138 (1–2): 171—4. PMID 8125298. doi:10.1016/0378-1119(94)90802-8. 
• Lawton MP, Cashman JR, Cresteil T, et al. (1994). „A nomenclature for the mammalian flavin-containing monooxygenase gene family based on amino acid sequence identities”. Arch. Biochem. Biophys. 308 (1): 254—7. PMID 8311461. doi:10.1006/abbi.1994.1035. 
• Overby LH, Carver GC, Philpot RM (1997). „Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans”. Chem. Biol. Interact. 106 (1): 29—45. PMID 9305407. doi:10.1016/S0009-2797(97)00055-0. 
• Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). „Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library”. Gene. 200 (1–2): 149—56. PMID 9373149. doi:10.1016/S0378-1119(97)00411-3. 
• Chung WG, Park CS, Roh HK, et al. (2001). „Oxidation of ranitidine by isozymes of flavin-containing monooxygenase and cytochrome P450”. Jpn. J. Pharmacol. 84 (2): 213—20. PMID 11128045. doi:10.1254/jjp.84.213. 
• Janmohamed A, Dolphin CT, Phillips IR, Shephard EA (2001). „Quantification and cellular localization of expression in human skin of genes encoding flavin-containing monooxygenases and cytochromes P450”. Biochem. Pharmacol. 62 (6): 777—86. PMID 11551524. doi:10.1016/S0006-2952(01)00718-3. 
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). „Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences”. Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899—903. PMC 139241 . PMID 12477932. doi:10.1073/pnas.242603899. 
• Krause RJ, Lash LH, Elfarra AA (2003). „Human kidney flavin-containing monooxygenases and their potential roles in cysteine s-conjugate metabolism and nephrotoxicity”. J. Pharmacol. Exp. Ther. 304 (1): 185—91. PMID 12490590. doi:10.1124/jpet.102.042911. 
• Furnes B, Feng J, Sommer SS, Schlenk D (2003). „Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans”. Drug Metab. Dispos. 31 (2): 187—93. PMID 12527699. doi:10.1124/dmd.31.2.187. 
• Ota T, Suzuki Y, Nishikawa T, et al. (2004). „Complete sequencing and characterization of 21,243 full-length human cDNAs”. Nat. Genet. 36 (1): 40—5. PMID 14702039. doi:10.1038/ng1285. 
• Zhang J, Cashman JR (2006). „Quantitative analysis of FMO gene mRNA levels in human tissues”. Drug Metab. Dispos. 34 (1): 19—26. PMID 16183778. doi:10.1124/dmd.105.006171. 
• Gregory SG, Barlow KF, McLay KE, et al. (2006). „The DNA sequence and biological annotation of human chromosome 1”. Nature. 441 (7091): 315—21. PMID 16710414. doi:10.1038/nature04727.